Vaccine Center, LLC v. GlaxoSmithKline LLC et al

Filing 166

ORDER Striking 160 Exhibit(s), which shall remain under seal. Defendant GlaxoSmithKline, LLC is to file an Amended Motion for Summary Judgment with a new citation no later than 8/11/2014. Signed by Magistrate Judge Nancy J. Koppe on 8/7/2014. (Copies have been distributed pursuant to the NEF - SLD)

1
2
3
4
5
UNITED STATES DISTRICT COURT
6
DISTRICT OF NEVADA
7
8
THE VACCINE CENTER LLC,

13

)
)
)
)
)
)
)
)
)
)

14

Pending before the Court is an order to show cause regarding the sealing of Docket No. 160.

15

See Docket No. 162. The response to that order to show cause indicates that the cited information is

16

available through other, public sources. See Docket No. 163 at 2.1 On August 7, 2014, the Court

17

held a hearing at which it discussed the possibility of GlaxoSmithKline substituting its citation in the

18

motion for summary judgment with another citation that does not implicate any confidentiality

19

issues. Having now considered the matter further, the Court hereby STRIKES Docket No. 160,

20

which shall remain under seal. The Court further ORDERS GlaxoSmithKline to file, no later than

21

August 11, 2014, an amended motion for summary judgment with a new citation.

9
Plaintiff(s),
10
vs.
11
GLAXOSMITHKLINE LLC, et al.,
12
Defendants.

22

ORDER STRIKING DOCKET NO. 160
ORDER THAT DEFENDANT
GLAXOSMITHKLINE FILE AN
AMENDED MOTION FOR
SUMMARY JUDGMENT

IT IS SO ORDERED.

23

Case No. 2:12-cv-01849-JCM-NJK

DATED: August 7, 2014

24

______________________________________
NANCY J. KOPPE
United States Magistrate Judge

25
26
27
1

28

The cited information is located in approximately one page of the 24-page exhibit. See Docket
No. 160. Defendants sought to redact the other 23 pages of the exhibit. See Docket No. 163 at 4.